20,024 Shares in Thermo Fisher Scientific Inc. (TMO) Purchased by Cobiz Wealth LLC

Cobiz Wealth LLC purchased a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 20,024 shares of the medical research company’s stock, valued at approximately $3,802,000.

Several other institutional investors have also recently modified their holdings of TMO. Covington Capital Management grew its position in Thermo Fisher Scientific by 0.9% during the second quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after buying an additional 20 shares during the period. Investment Centers of America Inc. grew its position in Thermo Fisher Scientific by 1.6% during the second quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after buying an additional 21 shares during the period. Fort Washington Investment Advisors Inc. OH grew its position in Thermo Fisher Scientific by 0.4% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after buying an additional 23 shares during the period. Bienville Capital Management LLC grew its position in Thermo Fisher Scientific by 1.6% during the second quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after buying an additional 27 shares during the period. Finally, Pictet North America Advisors SA grew its position in Thermo Fisher Scientific by 2.8% during the second quarter. Pictet North America Advisors SA now owns 1,764 shares of the medical research company’s stock worth $308,000 after buying an additional 48 shares during the period. Institutional investors and hedge funds own 86.22% of the company’s stock.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $191.74, for a total value of $9,587,000.00. Following the sale, the chief executive officer now owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.49% of the stock is owned by corporate insiders.

Several brokerages have weighed in on TMO. Jefferies Group restated a “hold” rating and set a $195.00 target price on shares of Thermo Fisher Scientific in a research report on Thursday, September 28th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a research report on Saturday. BTIG Research began coverage on shares of Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 target price on the stock. Goldman Sachs Group began coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. Finally, Barclays restated an “overweight” rating and set a $215.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Monday, September 25th. Two investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $212.21.

Shares of Thermo Fisher Scientific Inc. (TMO) traded up $1.81 during midday trading on Tuesday, hitting $215.32. 1,230,200 shares of the company’s stock traded hands, compared to its average volume of 1,552,686. Thermo Fisher Scientific Inc. has a 12 month low of $140.00 and a 12 month high of $215.33. The stock has a market capitalization of $85,820.00, a P/E ratio of 36.56, a PEG ratio of 1.74 and a beta of 1.06. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the firm earned $2.03 earnings per share. The company’s revenue for the quarter was up 13.9% compared to the same quarter last year. equities research analysts expect that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, January 15th. Shareholders of record on Friday, December 15th were issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend was Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 10.19%.

TRADEMARK VIOLATION WARNING: “20,024 Shares in Thermo Fisher Scientific Inc. (TMO) Purchased by Cobiz Wealth LLC” was reported by Week Herald and is the sole property of of Week Herald. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://weekherald.com/2018/01/23/20024-shares-in-thermo-fisher-scientific-inc-tmo-purchased-by-cobiz-wealth-llc.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply